Prion Disease
Humoral immune response to prion protein correlates with protection
Published in Vaccine Weekly, December 15th, 2004
"Prion diseases are characterized by the deposition of an abnormal form (termed PrPSc) of the cellular prion protein (PrPC). Because antibodies to PrPC can antagonize deposition of PrPSc in cultured cells and mice, they may be useful for anti-prion therapy. However, induction of protective anti-prion immune responses in WT animals may be hindered by host tolerance. Here, we studied the cellular and molecular basis of tolerance to PrPC. Immunization of PrnPo/o mice with bacterially expressed PrP...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
Source: Vaccine Weekly (2004-12-15)
More Articles from Vaccine Weekly
- AIDS/HIV Vaccine
Non-neutralizing anti-HIV-1 antibody becomes neutralizing antibody - AIDS/HIV Vaccine
Three vectors encoding SIV antigens protected against SIV CD4+ T-cell loss - Allergy Vaccine
Epitope modulation of Bet v 1 reduces IgE binding but retains protein folding - Autoimmune Disease
Therapeutic vaccination using CD4+CD25+ antigen-specific regulatory T cells - Cancer Vaccine
Unique antigens for therapeutic cancer vaccines reviewed - AIDS/HIV Vaccine
Antigenicity of HIV-1 p24 produced in high yields from plants was preserved - More from this issue of Vaccine Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
